For Immediate Release: August 19, 2016
AtlantiCare Regional Medical Center's Wound Healing Center, with locations in Egg Harbor Township and Hammonton, New Jersey, has earned Healogic's Center of Distinction Award.
The Center, a member of the Healogics network of advanced wound care services, achieved outstanding clinical outcomes for twelve consecutive months, including patient satisfaction, wound healing rates and days to heal. There were 512 Centers eligible for the Center of Distinction award. AtlantiCare's sites were two of 221 centers that achieved the honor.
ARMC's Wound Healing Center Team treats patients by appointment and referral from their primary or specialty care physician. The team cares for diabetic ulcers, pressure ulcers, gangrene, bone infections, bone grafts, infections following amputation, and other chronic wounds which have not healed in a reasonable amount of time. Advanced treatments include negative pressure wound therapy, bio-engineered skin substitutes, hyperbaric oxygen therapy (at the Egg Harbor Township location), biological and biosynthetic dressings and growth factor therapies.
AtlantiCare, a member of Geisinger Health System, is an integrated system of services designed to help people achieve optimal health. It includes AtlantiCare Regional Medical Center, AtlantiCare Health Engagement, the AtlantiCare Foundation, and AtlantiCare Health Services. Its more than 5,400 employees and more than 700 physicians serve the community in nearly 70 locations. A 2009 Malcolm Baldrige Award winner, AtlantiCare was also included in Modern Healthcare's Best Places to Work in Healthcare in 2010. ARMC became the 105th hospital in the nation to attain status as a Magnet™ designated hospital in March of 2004 and was redesignated a Magnet™ hospital in 2008 and 2013.
Headquartered in Jacksonville, Fla., Healogics is the nation's largest provider of advanced wound care services. Healogics and its affiliated companies manage nearly 800 Wound Care Centers® in the nation and saw approximately 285,000 new patients in 2015 through a connected network of partner hospitals and Wound Care Centers, academic medical centers, and other post‐acute sites. Healogics utilizes an evidence‐based systematic approach to chronic wound healing to treat an underserved and growing patient population. A fund managed by Clayton, Dubilier & Rice, a private investment firm, is the majority shareholder of Healogics. For more information, please visit www.healogics.com.